Icon

FOSAMAX (nda020560)- (EQ 10MG BASE,EQ 40MG BASE,EQ 5MG BASE,EQ 35MG BASE,EQ 70MG BASE)

ALENDRONATE SODIUM ORGANON
EQ 10MG BASE,EQ 40MG BASE,EQ 5MG BASE,EQ 35MG BASE,EQ 70MG BASE
Yes No
2018-Jul-17 Expired
None None
None No
FOSAMAX is a bisphosphonate indicated for: • Treatment and prevention of osteoporosis in postmenopausal women • Treatment to increase bone mass in men with osteoporosis • Treatment of glucocorticoid-induced osteoporosis • Treatment of Paget's disease of bone
8 0 2
Total Other Developers None
Drugs with Suitability No
EQ 10MG BASE ** ** - - 1
EQ 40MG BASE ** ** - - -
EQ 5MG BASE ** ** - - -
EQ 35MG BASE ** ** - 2 -
EQ 70MG BASE ** ** - - 2
NDA Sales Available Total Generic Sales Available
No 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ****** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ***** **** *** ***** ******** *.*.*. *********** ****** ****** ********** **, ******, *****, ******* (***) ***
****** ***** ***** ******* *********** **** ** ****, *-*** ** *-***, *-*** ** *-***, **** ** *-***/*/*/*, *-****, *-***, *-***, *-***, ***** ********** ****, ********, *** ******, ***** (***) ***
****** ***** ***** ****** *** *********** *** *** *** ********* ** ***** *, *, *-* & *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ***** ***** ******* *********** **** *-*, *-**, *-** **** ********** ****, ******** *******, ******-*****, ****, *********** ******, ***** (***) ***
****** ******** ******** ************ *** *********** ** ******** ******, ******, *** ****** (**) *****, ****** ****** (***) ***
****** ******** ******** ******** ******** ******** ************** **.,*** *********** *** ***'** **** ******** ********, ********, ******** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.